You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
中牧股份(600195.SH):乾元浩鄭州廠獲准生產高致病性禽流感疫苗並核發獸藥產品批准文號
格隆匯 12-23 16:26

格隆匯 12 月 23日丨中牧股份(600195.SH)公佈,根據《獸藥管理條例》和《獸藥產品批准文號管理辦法等有關規定,經農業農村部審查,准予公司控股子公司乾元浩生物股份有限公司鄭州生物藥廠(乾元浩鄭州廠”)生產高致病性禽流感疫苗,並核發獸藥產品批准文號,通用名稱重組禽流感病毒(H5+H7)三價滅活疫苗(H5N1 Re-11+Re-12株,H7N9 H7-Re3株)。

按照《口蹄疫、高致病性禽流感疫苗生產企業設置規劃》(農醫發[2016]37號)相關規定,該產品批准文號是乾元浩鄭州廠生產線通過生物安全三級防護標準驗收,並取得河南省農業農村廳核發的《獸藥生產許可證》和《獸藥GMP證書》等資質文件的基礎上,履行產品批准文號換髮程序所取得的產品批准文號。

目前,乾元浩鄭州廠已按照《獸藥管理條例》、《獸藥產品批准文號管理辦法》的要求取得獸藥產品批准文號批件該產品上市銷售前,還需履行農業農村部的批簽發審批流程。

高致病性禽流感疫苗屬於國家強制免疫所需的獸用生物製品,根據《獸藥管理條例》的規定,由國務院獸醫行政管理部門指定的企業生產。乾元浩鄭州廠的生產線通過生物安全三級防護標準驗收並取得《獸藥生產許可證》和《獸藥GMP證書後,取得高致病性禽流感疫苗的產品批准文號,有利於其組織產品生產上市銷售,更好地滿足市場需求,保障市場供應。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account